Idorsia Ltd. (IDRSF)
5.30
-0.30
(-5.36%)
USD |
OTCM |
Sep 24, 16:00
Idorsia Cash and Short Term Investments (Quarterly) : 109.95M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 109.95M |
| March 31, 2026 | 117.85M |
| December 31, 2025 | 111.76M |
| September 30, 2025 | 89.49M |
| June 30, 2025 | 104.60M |
| March 31, 2025 | 73.29M |
| December 31, 2024 | 137.22M |
| September 30, 2024 | 103.15M |
| June 30, 2024 | 275.99M |
| March 31, 2024 | 385.88M |
| December 31, 2023 | 187.51M |
| September 30, 2023 | 290.92M |
| June 30, 2023 | 48.94M |
| March 31, 2023 | 240.84M |
| December 31, 2022 | 514.83M |
| September 30, 2022 | 711.23M |
| June 30, 2022 | 772.57M |
| March 31, 2022 | 1.033B |
| December 31, 2021 | 1.139B |
| Date | Value |
|---|---|
| September 30, 2021 | 1.341B |
| June 30, 2021 | 1.005B |
| March 31, 2021 | 923.05M |
| December 31, 2020 | 1.143B |
| September 30, 2020 | 888.01M |
| June 30, 2020 | 768.79M |
| March 31, 2020 | 466.86M |
| December 31, 2019 | 767.35M |
| September 30, 2019 | 596.39M |
| June 30, 2019 | 703.14M |
| March 31, 2019 | 815.20M |
| December 31, 2018 | 936.97M |
| September 30, 2018 | 822.14M |
| June 30, 2018 | 704.28M |
| March 31, 2018 | 799.77M |
| December 31, 2017 | 863.45M |
| September 30, 2017 | 725.06M |
| June 30, 2017 | 790.54M |
| March 31, 2017 | 626.73M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 5.259B |
| AC Immune SA | 93.42M |
| CRISPR Therapeutics AG | 2.365B |